MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward ®) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering ...

Lifeward announces approval for ReWalk 7 coverage by a major U.S. health insurer, enhancing access for individuals with spinal cord injuries. Approval for reimbursement by a major insurer comes ...

Lifeward Ltd. reported its financial results for the first quarter of 2025, highlighting a continuing build-up of opportunities for the ReWalk exoskeleton with over 120 qualified leads. The company's ...

ReWalk Robotics Ltd. misses on earnings expectations. Reported EPS is $-0.58 EPS, expectations were $-0.25. Operator: Good day, and welcome to the Second Quarter 2025 Lifeward Conference Call.

Research at the prestigious Semmelweis University, Budapest, Hungary has led the way in achieving government coverage in Hungary with a code for exoskeleton training that expands access to additional ...

ReWalk Robotics Ltd. misses on earnings expectations. Reported EPS is $-0.73 EPS, expectations were $-0.7. Operator: Good day, and welcome to the Life Ward First Quarter 2024 Earnings Conference Call.